Five things to know:
1. Geisinger’s outlook is stable, and it has about $1.3 billion of debt outstanding, according to Moody’s.
2. The downgrade reflects expectations that Geisinger’s will lead to weak operating cash flow for a protracted period.
3. The “A2” rating reflects expectations that Geisinger will continue to benefit from its clinical footprint of tertiary and quaternary services and leading market capture across central and northeastern Pennsylvania. Moody’s said this will be supported by strong brand recognition and system growth initiatives.
4. Factors that could lead to a rating upgrade include stronger and sustained operating cash flow margins and strengthening of balance sheet metrics.
5. Failure to improve operating performance to targeted levels could result in further rating downgrades.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
